Healthcare -
Biotechnology - NASDAQ - US
$ 9.865
-2.23 %
$ 1.02 B
Market Cap
-1.88
P/E
NTLA - GROSS PROFIT
Gross Profit NTLA - Intellia Therapeutics, Inc.
27.3 M
LAST VALUE
2.15%
2 YEAR CAGR
19.78%
5 YEAR CAGR
0.00%
10 YEAR CAGR